The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
541 - Can you please advise if CADTH Common Drug Review publications can be used as evidence for efficacy, pharmacoeconomic or recommendation claims?
-
No. These reviews have important uses (e.g. explaining recommendations for funding decisions) but they are not designed or intended to support product claims in drug advertising. Please refer to the PAAB Tips document Marketing Benefit Claims http://www.paab.ca/Marketing_Benefit_Claims_-_June_22.pdf for the evidentiary requirements relating to common types of claims.
